Clinical trialUNITERARE2 days ago
New Recruiting Trial: Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy
Researchers are testing a new treatment for head and neck cancer that comes back after radiation therapy. The treatment combines radiation therapy again with a drug called chidamide, which helps boost the body's immune system to fight cancer cells. This is an early-stage study (Phase 1) just starting to recruit patients in 2026.
WHY IT MATTERSThis trial offers a potential new option for patients with recurrent head and neck squamous cell carcinoma who have limited treatment choices after their cancer returns following initial radiation therapy.